Xingyu Mu Selected Research

Xingyu Mu Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
4	Carcinogenesis 10/2023 - 01/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2018
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2021
3	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 01/2020
2	Pancreatitis 01/2024 - 01/2023
2	Obesity 01/2024 - 01/2023
2	Plasmacytoma 01/2021 - 01/2020
1	Renal hypouricemia 01/2024
1	Cholecystitis 01/2023
1	Cholelithiasis 01/2023
1	Porokeratosis (Palmoplantar Porokeratosis) 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Paranoid Personality Disorder 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
2	tirzepatideIBA 01/2024 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 01/2020
1	Uric Acid (Urate)IBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	AntigensIBA 11/2023
1	semaglutideIBA 01/2023
1	AntibodiesIBA 01/2023
1	Insulin Glargine (Lantus)FDA Link 01/2023
1	dulaglutideIBA 01/2023
1	insulin degludecIBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	tofacitinibIBA 01/2023
1	Tuberculin (PPD)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Circular RNAIBA 01/2022
1	ChromatinIBA 01/2022
1	DeoxyuridineIBA 01/2022
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Bovine Serum AlbuminIBA 01/2022
1	6-methyladenineIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	CholesterolIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	AndrogensIBA 01/2020
1	Polyglactin 910IBA 10/2018
1	ArrestinsIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	TensinsIBA 01/2017
1	Ubiquitin-Specific ProteasesIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2019
1	Contraindications 01/2021
1	Intra-Arterial Infusions 01/2021
1	Castration 01/2020
1	Palliative Care (Palliative Therapy) 12/2019
1	Radiotherapy 12/2019
1	Sutures (Suture) 10/2018